Market Cap 45.61M
Revenue (ttm) 60,000.00
Net Income (ttm) -49.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -83,033.33%
Debt to Equity Ratio -0.96
Volume 4,643,500
Avg Vol 5,496,708
Day's Range N/A - N/A
Shares Out 2.88M
Stochastic %K 90%
Beta 2.47
Analysts Hold
Price Target $2.00

Company Profile

Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and...

Industry: Biotechnology
Sector: Healthcare
Phone: 917 289 1117
Address:
295 Madison Avenue, Suite 2400, New York, United States
Latest News on EYEN
No data available.